{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T11:37:36Z","timestamp":1792064256395,"version":"4.4.0"},"reference-count":12,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","jamda.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Medical Directors Association"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.jamda.2017.06.010","type":"journal-article","created":{"date-parts":[[2017,7,21]],"date-time":"2017-07-21T09:30:53Z","timestamp":1500629453000},"page":"799-802","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Efficacy and Safety of Citalopram Compared to Atypical Antipsychotics on Agitation in Nursing Home Residents With Alzheimer Dementia"],"prefix":"10.1016","volume":"18","author":[{"given":"Giovanni","family":"Viscogliosi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iulia Maria","family":"Chiriac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evaristo","family":"Ettorre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jamda.2017.06.010_bib1","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1056\/NEJMoa061240","article-title":"Effectiveness of atypical antipsychotic drugs in patients with Alzheimer\u2019s disease","volume":"355","author":"Schneider","year":"2006","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jamda.2017.06.010_bib2","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1001\/jama.294.15.1934","article-title":"Risk of death with atypical antipsychotic drug treatment for dementia","volume":"294","author":"Schneider","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.jamda.2017.06.010_bib3","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1001\/jama.2014.93","article-title":"Effect of citalopram on agitation in Alzheimer disease: The CitAD randomized clinical trial","volume":"311","author":"Porsteinsson","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.jamda.2017.06.010_bib4","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/j.jagp.2015.05.006","article-title":"Time to response to citalopram treatment for agitation in Alzheimer\u2019s disease","volume":"23","author":"Weintraub","year":"2015","journal-title":"Am J Geriatr Psychiatry"},{"key":"10.1016\/j.jamda.2017.06.010_bib5","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1097\/JGP.0b013e3180cc1ff5","article-title":"A\u00a0double-blind comparison of citalopram and risperidone for the treatment of behavioral and psychotic symptoms associated with dementia","volume":"15","author":"Pollock","year":"2007","journal-title":"Am J Geriatr Psychiatry"},{"key":"10.1016\/j.jamda.2017.06.010_bib6","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.1212\/WNL.44.12.2308","article-title":"The Neuropsychiatric Inventory: Comprehensive assessment of psychopathology in dementia","volume":"44","author":"Cummings","year":"1994","journal-title":"Neurology"},{"key":"10.1016\/j.jamda.2017.06.010_bib7","doi-asserted-by":"crossref","first-page":"S22","DOI":"10.1097\/00002093-199700112-00004","article-title":"Validity and reliability of the Alzheimer\u2019s Disease Cooperative Study\u2013Clinical Global Impression of Change","volume":"11","author":"Schneider","year":"1997","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"10.1016\/j.jamda.2017.06.010_bib8","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1176\/appi.ajp.2008.07111779","article-title":"Clinical symptom responses to atypical antipsychotic medications in Alzheimer\u2019s disease: Phase 1 outcomes from the CATIE-AD effectiveness trial","volume":"165","author":"Sultzer","year":"2008","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.jamda.2017.06.010_bib9","first-page":"253","article-title":"Institutional placement of persons with dementia: What predicts occurrence and timing?","volume":"13","author":"Coehlo","year":"2007","journal-title":"J\u00a0Fam Nurs"},{"key":"10.1016\/j.jamda.2017.06.010_bib10","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1097\/01.JGP.0000196628.12010.35","article-title":"Quetiapine treatment of psychosis associated with dementia: A double-blind, randomized, placebo-controlled clinical trial","volume":"14","author":"Tariot","year":"2006","journal-title":"Am J Geriatr Psychiatry"},{"key":"10.1016\/j.jamda.2017.06.010_bib11","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1176\/appi.ajp.2013.12081046","article-title":"The long-term effects of conventional and atypical antipsychotics in patients with probable Alzheimer\u2019s disease","volume":"170","author":"Lopez","year":"2013","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.jamda.2017.06.010_bib12","first-page":"CD008191","article-title":"Antidepressants for agitation and psychosis in dementia","author":"Seitz","year":"2011","journal-title":"Cochrane Database Syst Rev"}],"container-title":["Journal of the American Medical Directors Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525861017303419?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525861017303419?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,29]],"date-time":"2018-08-29T22:26:55Z","timestamp":1535581615000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525861017303419"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":12,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2017,9]]}},"alternative-id":["S1525861017303419"],"URL":"https:\/\/doi.org\/10.1016\/j.jamda.2017.06.010","relation":{},"ISSN":["1525-8610"],"issn-type":[{"value":"1525-8610","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and Safety of Citalopram Compared to Atypical Antipsychotics on Agitation in Nursing Home Residents With Alzheimer Dementia","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Medical Directors Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jamda.2017.06.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 AMDA - The Society for Post-Acute and Long-Term Care Medicine.","name":"copyright","label":"Copyright"}]}}